PRESCRIBING FOR CHILDREN AND ADOLESCENTS Off-label prescribing is when a physician gives you a drug that the U.S. Food and Drug Administration

PRESCRIBING FOR CHILDREN AND ADOLESCENTS

Off-label prescribing is when a physician gives you a drug that the U.S. Food and Drug Administration (FDA) has approved to treat a condition different than your condition. This practice is legal and common. In fact, one in five prescriptions written today are for off-label use.

—Agency for Healthcare Research and Quality

Psychotropic drugs are commonly used for children and adolescents to treat mental health disorders, yet many of these drugs are not FDA approved for use in these populations. Thus, their use is considered “off-label,” and it is often up to the best judgment of the prescribing clinician. As a PMHNP, you will need to apply the best available information and research on pharmacological treatments for children in order to safely and effectively treat child and adolescent patients. Sometimes this will come in the form of formal studies and approvals for drugs in children. Other times you may need to extrapolate from research or treatment guidelines on drugs in adults. Each individual patient case will need to be considered independently and each treatment considered from a risk assessment standpoint. What psychotherapeutic approach might be indicated as an initial treatment? What are the potential side effects of a particular drug?

For this Assignment, you consider these questions and others as you explore FDA-approved (“on label”) pharmacological treatments, non-FDA-approved (“off-label”) pharmacological treatments, and nonpharmacological treatments for disorders in children and adolescents.

Reference:

Agency for Healthcare Research and Quality. (2015). 
Off-label drugs: What you need to know.

TO PREPARE

· Your Instructor will assign a specific disorder for you to research for this Assignment.

· Use the Walden library to research evidence-based treatments for your assigned disorder in children and adolescents. You will need to recommend one FDA-approved drug, one off-label drug, and one nonpharmacological intervention for treating this disorder in children and adolescents.

THE ASSIGNMENT (1–2 PAGES)

· Recommend one FDA-approved drug, one off-label drug, and one nonpharmacological intervention for treating your assigned disorder in children and adolescents.

· Explain the risk assessment you would use to inform your treatment decision making. What are the risks and benefits of the FDA-approved medicine? What are the risks and benefits of the off-label drug?

· Explain whether clinical practice guidelines exist for this disorder and, if so, use them to justify your recommendations. If not, explain what information you would need to take into consideration.

· Support your reasoning with at least three scholarly resources, one each on the FDA-approved drug, the off-label, and a non-medication intervention for the disorder. Attach the PDFs of your sources.

BY DAY 7 OF WEEK 3

Submit your Assignment. 

· Hilt, R. J., & Nussbaum, A. M. (2025). 
DSM-5-TR pocket guide for child and adolescent mental health . American Psychiatric Association Publishing.

· Chapter 7, “Reaching a DSM-5-TR Pediatric Diagnosis When You Have 45 Minutes or More” (pp. 185 – 186)

· Chapter 10, “Organizing a Comprehensive Pediatric Mental Status Examination With a Psychiatric Glossary” (pp. 213 – 217)

· Chapter 11, “Using DSM-5-TR Assessment Measures to Aid Diagnosis” (pp. 221 – 248)

· Chapter 15, “Initiating Psychosocial Interventions” (pp. 285 – 294)

· Chapter 16, “Starting Psychotherapy” (pp. 295 – 302)

· Chapter 17, “Initiating Medications and Monitoring for Adverse Effects” (pp. 303 – 330)

· Thapar, A., Pine, D. S., Leckman, J. F., Scott, S., Snowling, M. J., & Taylor, E. A. (2015). 
Rutter’s child and adolescent psychiatry  (6th ed.). Wiley Blackwell.

· Chapter 43, “Pharmacological, Medically-Led and Related Treatments”

· Walden University. (n.d.). 

Developing SMART goals
 Links to an external site.
. to an external site.

· Zakhari, R. (2020). 
The psychiatric-mental health nurse practitioner certification review manual . Springer.

· Chapter 5, “Psychopharmacology”

· CriticalThinkRx. (2019, June 9). 

Module 5:
  
Links to an external site.


Specific drug classes: Focus on adverse effects
Links to an external site.


  [Video]. YouTube. to an external site.

· CriticalThinkRx. (2019, June 9). 

Module 2: Use of psychotropics with youth_prevalence and concerns
 Links to an external site.
 [Video]. YouTube.

Share This Post

Email
WhatsApp
Facebook
Twitter
LinkedIn
Pinterest
Reddit

Order a Similar Paper and get 15% Discount on your First Order

Related Questions

1. Management Plan: Write a final management plan for the client you presented with bulimia. Include the following components in the management

1. Management Plan: Write a final management plan for the client you presented with bulimia. Include the following components in the management plan: a. Primary diagnosis b. Recommended diagnostic testing based on clinical practice guidelines c. Medications d. Nonpharmacologic interventions e. Recommended follow-up schedule and referrals with rationale 2. Analysis:

  iscuss one of these topics as a developmental issue occurring during the newborn, preschool, school-age, or adolescent period. Include your

  iscuss one of these topics as a developmental issue occurring during the newborn, preschool, school-age, or adolescent period. Include your recommendations and patient teachings. Autism Spectrum Disorder Cerebral Palsy Depression Developmental Disabilities Fetal Alcohol Spectrum Disorders Fragile X Syndrome Hemophilia Language and Speech Disorders Learning Disorders Muscular Dystrophy Oppositional

READ BELOW- Presentation: Demographics, onset of symptoms, history of present illness, associated risk factors  Dementia and delirium are both

READ BELOW- Presentation: Demographics, onset of symptoms, history of present illness, associated risk factors  Dementia and delirium are both conditions that present a challenge to a person’s functional capacity, however, they contrast in their pathophysiology, presentation, duration, and treatment methods. It is important to note that both conditions have the

   M2 M2 covers chapters 8 through 13 of the textbooks. TEXTBOOK(S) AND REQUIRED MATERIALS: Title: The Marriage and Family Experience: Intimate

   M2 M2 covers chapters 8 through 13 of the textbooks. TEXTBOOK(S) AND REQUIRED MATERIALS: Title: The Marriage and Family Experience: Intimate Relationships In A Changing Society  Author: Theodore F. Cohen and Bryan Strong  Publisher: Cengage Learning  Year Published: 2021 Edition: 14th ISBN: 13: 9780357378229 Please answer the following questions.

  The first Administrative Safeguard in the Security Rule Standards is the Security Management Process standard.  The Security Management Process

  The first Administrative Safeguard in the Security Rule Standards is the Security Management Process standard.  The Security Management Process standard has four required implementation specifications.  Two of these are Risk Analysis and Risk Management.   Risk Analysis and Risk Management are the foundation upon which an entity’s necessary security activities are built.  Security Risk

Chapter 7( find in the attachement) Data collection is a fundamental aspect of quantitative research, and this chapter provides valuable insights into

Chapter 7( find in the attachement) Data collection is a fundamental aspect of quantitative research, and this chapter provides valuable insights into different approaches for gathering data. Discuss the pros and cons of various data collection methods, such as in-person collection, computer-assisted telephone interviewing (CATI), and virtual data collection via online